Clinical Trial Update: Optimizing Prograf® Therapy in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating optimization of tacrolimus (Prograf) therapy in renal transplant patients. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED